Technical Analysis for PSTX - Poseida Therapeutics, Inc.

Grade Last Price % Change Price Change
D 3.06 -4.97% -0.16
PSTX closed down 4.97 percent on Monday, March 18, 2024, on 63 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
3 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down

Date Alert Name Type % Chg
Calm After Storm Range Contraction 0.00%
NR7 Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
50 DMA Resistance Bearish -4.97%
Calm After Storm Range Contraction -4.97%
Wide Bands Range Expansion -4.97%
Fell Below 50 DMA Bearish -5.56%
MACD Bearish Centerline Cross Bearish -5.56%
Calm After Storm Range Contraction -5.56%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 11 hours ago
Up 1% about 13 hours ago
Down 5% about 14 hours ago
Down 3% about 15 hours ago
Fell Below Previous Day's Low about 15 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of non-viral gene engineering technologies for the treatment of hematological malignancies and solid tumors. Its products pipeline include autologous and allogeneic chimeric antigen receptor T cell, or CAR-T. The company was founded by Eric M. Ostertag in 2014 and is headquartered in San Diego, CA.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Biopharmaceutical Life Sciences Clinical Medicine Solid Tumors Immune System Cancer Treatment Lymphoma Leukemia Chimeric Antigen Receptor T Cell Hematological Malignancies Chimeric Antigen Receptor Cellectis

Is PSTX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 4.27
52 Week Low 1.54
Average Volume 777,143
200-Day Moving Average 2.60
50-Day Moving Average 3.39
20-Day Moving Average 3.51
10-Day Moving Average 3.41
Average True Range 0.36
RSI (14) 42.86
ADX 24.32
+DI 15.44
-DI 25.02
Chandelier Exit (Long, 3 ATRs) 3.20
Chandelier Exit (Short, 3 ATRs) 3.93
Upper Bollinger Bands 4.10
Lower Bollinger Band 2.92
Percent B (%b) 0.12
BandWidth 33.60
MACD Line -0.06
MACD Signal Line 0.02
MACD Histogram -0.0767
Fundamentals Value
Market Cap 292.61 Million
Num Shares 95.6 Million
EPS -1.54
Price-to-Earnings (P/E) Ratio -1.99
Price-to-Sales 6.92
Price-to-Book 2.78
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.40
Resistance 3 (R3) 3.43 3.35 3.34
Resistance 2 (R2) 3.35 3.27 3.34 3.32
Resistance 1 (R1) 3.21 3.21 3.17 3.17 3.30
Pivot Point 3.13 3.13 3.11 3.11 3.13
Support 1 (S1) 2.98 3.04 2.94 2.95 2.82
Support 2 (S2) 2.90 2.99 2.89 2.80
Support 3 (S3) 2.76 2.90 2.78
Support 4 (S4) 2.72